ondansetron has been researched along with Intertrochanteric Fractures in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papadopoulos, G | 1 |
| Pouangare, M | 1 |
| Papathanakos, G | 1 |
| Arnaoutoglou, E | 1 |
| Petrou, A | 1 |
| Tzimas, P | 1 |
1 trial available for ondansetron and Intertrochanteric Fractures
| Article | Year |
|---|---|
The effect of ondansetron on postoperative delirium and cognitive function in aged orthopedic patients.
Topics: Aged; Anesthesia, General; Cognition Disorders; Delirium; Double-Blind Method; Female; Femoral Fract | 2014 |